Exclusive distribution model ending

AstraZeneca will use a new distribution model from February 2019 claiming the new model won’t cherry-pick and there will be no exclusive distribution.

Currently, pharmacists can order all AstraZeneca medicines via DHL and from 01 February 2019, pharmacists will also be able to order the full range through their preferred wholesaler.

In the announcement, AstraZeneca said it has listened to feedback from the industry.

AstraZeneca Country President Liz Chatwin said, “the new model will be competitive and will ensure pharmacists have contingencies for supply.

“As our environment is evolving, we need to change the way we make our medicines available,” she said. “Community pharmacy and wholesalers asked us for choice and access to all of our medicines. We are confident that our new model will provide this. It will be competitive and deliver for patients.”

Symbion CEO Brett Barons told Retail Pharmacy magazine that Symbion is pleased that AstraZeneca have listened to feedback from the industry because pharmacists wanted a choice.

“For some time, we have been hearing from our customers that the exclusive direct distribution model doesn’t work for pharmacists – a position that has been reiterated by the Guild.

“We are pleased that AstraZeneca has listened to the concerns of Pharmacists about the exclusive direct distribution model and we are also pleased that AstraZeneca is supporting the CSO distributors,” he said.

“This move shows that full-line CSO wholesalers are the best channel for the distribution of all PBS medicines across Australia.

“We also welcome the proposed changes to the CSO set to be introduced by the Federal Government and we have confidence in our ability to maintain our position as a wholesaler of choice.”

Pharmacy Guild of Australia National President, George Tambassis welcomed the change, thanking AstraZeneca for addressing one of the Guild’s key concerns regarding exclusive direct arrangements.

“Our members will now have choice to ensure patients have access to these important medicines from multiple sources,” he said.

AstraZeneca is partnering with Arrow Pharmaceuticals during the transition to support pharmacists and will also work with wholesalers to ensure they are able to access the full range, including the 14 AstraZeneca medicines, previously only made available via DHL.

Must Read

A new pathway to improved traumatic brain injury

A team of Australian researchers have developed a ‘new dictionary’ to better predict outcomes for people who have experienced traumatic brain injury (TBI). The Australian...